Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
25.19
+0.65 (2.65%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Indivior Market Cap
Indivior has a market cap or net worth of $3.14 billion as of October 16, 2025. Its market cap has increased by 140.96% in one year.
Market Cap
3.14B
Enterprise Value
3.00B
1-Year Change
140.96%
Ranking
Category
Stock Price
$25.19
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $3.14B, an increase of 105.35%. That is a compound annual growth rate of 6.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 3.06B | 97.11% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | 1.07B | 182.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |